Cargando…

Risk of cardiovascular disease among cancer survivors: Protocol of a pooled analysis of population-based cohort studies

INTRODUCTION: Cancer and cardiovascular disease remain leading causes of death and disability worldwide, which places a heavy burden on public health systems and causes widespread suffering. Because these entities have highly overlapping risk factors, including hyperlipidemia, hypertension, diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Botao, Mei, Zubing, Yu, Hang, Wang, Yan, Geng, Qian, Pu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391087/
https://www.ncbi.nlm.nih.gov/pubmed/35990968
http://dx.doi.org/10.3389/fcvm.2022.926218
_version_ 1784770792802746368
author Yu, Botao
Mei, Zubing
Yu, Hang
Wang, Yan
Geng, Qian
Pu, Jin
author_facet Yu, Botao
Mei, Zubing
Yu, Hang
Wang, Yan
Geng, Qian
Pu, Jin
author_sort Yu, Botao
collection PubMed
description INTRODUCTION: Cancer and cardiovascular disease remain leading causes of death and disability worldwide, which places a heavy burden on public health systems and causes widespread suffering. Because these entities have highly overlapping risk factors, including hyperlipidemia, hypertension, diabetes, obesity, smoking and other lifestyle factors, many studies have reported that they have similar etiological mechanisms. Accumulating evidence indicates that there is an increased risk of cardiovascular disease among cancer survivors compared with the general population. However, whether cancer is associated with an increased risk of cardiovascular disease remains controversial. METHODS AND ANALYSIS: We will conduct and report the meta-analysis strictly based on the Cochrane Handbook for Systematic Reviews and the Meta-analysis of Observational Studies in Epidemiology guidelines combined with the Preferred Reporting Items for Systematic Reviews and Meta-analysis for Protocols (PRISM-P). This meta-analysis was registered with PROSPERO (registration number CRD42022307056). We will search for studies published from database inception to December 1, 2021, regardless of language or date, in three electronic databases (PubMed, EMBASE, and Cochrane Library) to identify and appraise cohort studies examining the relationship between cancer and subsequent cardiovascular disease risk. The literature screening, inclusion and data extraction will be conducted independently by two investigators using pre-designed standardized data extraction forms. A senior investigator will be consulted in cases of disagreement. We will assess risk of bias in the included cohort studies using the Newcastle–Ottawa Scale (NOS). Quantitative synthesis will be conducted using a random-effects model. To explore potential sources of heterogeneity, we will carry out multiple sensitivity analysis, meta-regression and subgroup analysis according to baseline characteristics. Publication bias will be evaluated through visual inspection of funnel plot asymmetry as well as by Begg's rank correlation test and Egger's weighted linear regression test.
format Online
Article
Text
id pubmed-9391087
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93910872022-08-20 Risk of cardiovascular disease among cancer survivors: Protocol of a pooled analysis of population-based cohort studies Yu, Botao Mei, Zubing Yu, Hang Wang, Yan Geng, Qian Pu, Jin Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: Cancer and cardiovascular disease remain leading causes of death and disability worldwide, which places a heavy burden on public health systems and causes widespread suffering. Because these entities have highly overlapping risk factors, including hyperlipidemia, hypertension, diabetes, obesity, smoking and other lifestyle factors, many studies have reported that they have similar etiological mechanisms. Accumulating evidence indicates that there is an increased risk of cardiovascular disease among cancer survivors compared with the general population. However, whether cancer is associated with an increased risk of cardiovascular disease remains controversial. METHODS AND ANALYSIS: We will conduct and report the meta-analysis strictly based on the Cochrane Handbook for Systematic Reviews and the Meta-analysis of Observational Studies in Epidemiology guidelines combined with the Preferred Reporting Items for Systematic Reviews and Meta-analysis for Protocols (PRISM-P). This meta-analysis was registered with PROSPERO (registration number CRD42022307056). We will search for studies published from database inception to December 1, 2021, regardless of language or date, in three electronic databases (PubMed, EMBASE, and Cochrane Library) to identify and appraise cohort studies examining the relationship between cancer and subsequent cardiovascular disease risk. The literature screening, inclusion and data extraction will be conducted independently by two investigators using pre-designed standardized data extraction forms. A senior investigator will be consulted in cases of disagreement. We will assess risk of bias in the included cohort studies using the Newcastle–Ottawa Scale (NOS). Quantitative synthesis will be conducted using a random-effects model. To explore potential sources of heterogeneity, we will carry out multiple sensitivity analysis, meta-regression and subgroup analysis according to baseline characteristics. Publication bias will be evaluated through visual inspection of funnel plot asymmetry as well as by Begg's rank correlation test and Egger's weighted linear regression test. Frontiers Media S.A. 2022-08-05 /pmc/articles/PMC9391087/ /pubmed/35990968 http://dx.doi.org/10.3389/fcvm.2022.926218 Text en Copyright © 2022 Yu, Mei, Yu, Wang, Geng and Pu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Yu, Botao
Mei, Zubing
Yu, Hang
Wang, Yan
Geng, Qian
Pu, Jin
Risk of cardiovascular disease among cancer survivors: Protocol of a pooled analysis of population-based cohort studies
title Risk of cardiovascular disease among cancer survivors: Protocol of a pooled analysis of population-based cohort studies
title_full Risk of cardiovascular disease among cancer survivors: Protocol of a pooled analysis of population-based cohort studies
title_fullStr Risk of cardiovascular disease among cancer survivors: Protocol of a pooled analysis of population-based cohort studies
title_full_unstemmed Risk of cardiovascular disease among cancer survivors: Protocol of a pooled analysis of population-based cohort studies
title_short Risk of cardiovascular disease among cancer survivors: Protocol of a pooled analysis of population-based cohort studies
title_sort risk of cardiovascular disease among cancer survivors: protocol of a pooled analysis of population-based cohort studies
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391087/
https://www.ncbi.nlm.nih.gov/pubmed/35990968
http://dx.doi.org/10.3389/fcvm.2022.926218
work_keys_str_mv AT yubotao riskofcardiovasculardiseaseamongcancersurvivorsprotocolofapooledanalysisofpopulationbasedcohortstudies
AT meizubing riskofcardiovasculardiseaseamongcancersurvivorsprotocolofapooledanalysisofpopulationbasedcohortstudies
AT yuhang riskofcardiovasculardiseaseamongcancersurvivorsprotocolofapooledanalysisofpopulationbasedcohortstudies
AT wangyan riskofcardiovasculardiseaseamongcancersurvivorsprotocolofapooledanalysisofpopulationbasedcohortstudies
AT gengqian riskofcardiovasculardiseaseamongcancersurvivorsprotocolofapooledanalysisofpopulationbasedcohortstudies
AT pujin riskofcardiovasculardiseaseamongcancersurvivorsprotocolofapooledanalysisofpopulationbasedcohortstudies